The management of a globally recognised producer of phospholipids decided to start looking at downstream diversification into formulations on the EU market. The target company can be an established manufacturing company with own production program or just a contract manufacturing organization. Contact us to get information about this buyer.
The buyer is a large Indian company, operating in the field of pharmaceutical ingredients, nutritional supplements, cosmeceuticals and food ingredients. The company has been established in the early 2000s and it is growing rapidly. The company’s product portfolio covers for example
The company is very innovative and oriented at R&D, and although having a short history, the company has made a name in the industry quite fast.
The buyer can bring many synergies stemming from the acquisition, for example, higher integration with important pharmaceutical segments and markets in India. The buyer has already started with the screening of multiple targets in Europe, however, the management is still open to new possible targets.
Contact us to get details about this buyer of contract manufacturers for pharma industry
This buyer company is looking for an acquisition of a manufacturing organization, in order to be able to produce in the EU market. The target should, therefore, be compliant with cGMP or at least HACCP standards. Also, the target company should have some knowledge in European regulated pharmaceutical market.
The target should have experience with at least one of the following activities:
The revenue should exceed 2 million EUR to be interesting to the buyer. The EBITDA of the target is not important, as the buyer will pass some of its production into the facility. On the other hand, the target should not be in great loss. Ideally, if the target had between 10 to 50 employees.
Geographically, the target can be from any country in Europe. However, any low-cost EU member country such as Eastern or Southern Europe would be of great advantage.
The buyer is looking at companies, available for sale at max investment amount of 15 million EUR. The acquisition project shall be funded by the buyer company’s own funds, in case of larger acquisitions, bank financing will be involved.
Feel free to contact us for more information regarding this pharmaceutical contract manufacturer buyer in Europe, or if you know possible interested or suitable parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.
Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.